4/A//SEC Filing
Mayersohn Joel David 4/A
Accession 0001213900-25-124530
CIK 0001851484other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:10 PM ET
Size
5.2 KB
Accession
0001213900-25-124530
Insider Transaction Report
Form 4/AAmended
Mayersohn Joel David
Director
Transactions
- Award
Common Stock
2025-09-19+300,000→ 321,228 total
Footnotes (1)
- [F1]Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.
Documents
Issuer
CITIUS ONCOLOGY, INC.
CIK 0001851484
Entity typeother
Related Parties
1- filerCIK 0001588395
Filing Metadata
- Form type
- 4/A
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 4:10 PM ET
- Size
- 5.2 KB